Vitamin D and asthma.
REVIEW
Dermato-Endocrinology 4:2, 137–145; April/May/June 2012; G 2012 Landes Bioscience
Vitamin D and asthma
Sheena D. Brown,1 H. Hardie Calvert1 and Anne M. Fitzpatrick1,2,*
1
Department of Pediatrics; Emory University; Atlanta, GA USA; 2Children’s Healthcare of Atlanta Center for Developmental Lung Biology; Atlanta, GA USA
Keywords: vitamin D, asthma, asthma prevalence, children, inflammation
Abbreviations: 25(OH)D, 25-hydroxyvitamin D3; IgE, immunoglobulin E; IL, interleukin; TH2, T-helper cell type-2;
UVB, ultraviolet-B; VDR, vitamin D receptor
Asthma, one of the most prevalent diseases affecting people
worldwide, is a chronic respiratory disease characterized by
heightened airway inflammation, airway hyperresponsiveness
and airflow obstruction in response to specific triggers. While
the specific mechanisms responsible for asthma are not well
understood, changing environmental factors associated with
urban lifestyles may underlie the increased prevalence of the
disorder. Vitamin D is of particular interest in asthma since
vitamin D concentrations decrease with increased time spent
indoors, decreased exposure to sunlight, less exercise, obesity,
and inadequate calcium intake. Additionally, a growing body
of literature suggests that there is a relationship between
vitamin D status and respiratory symptoms, presumably
through immunomodulatory effects of vitamin D. This review
discusses vitamin D as it relates to asthma across the age
spectrum, with a focus on human studies.
.
e
nc
process involves smooth muscle hypertrophy, epithelial gobletcell hyperplasia and permanent deposition of airway extracellular
matrix proteins which may ultimately increase airflow obstruction
and the respiratory symptom burden of the disorder.9
Within industrialized Westernized countries, the prevalence of
asthma has steadily increased by 25% to 75% per decade since
1960, causing it to become a major public health concern.10-12
The increased prevalence of asthma may be influenced by
changing environmental factors associated with urban lifestyles.
Indeed, numerous dietary hypotheses have been proposed.13-15
Among the nutrients and antioxidants included in this hypothesis,
vitamin D is of particular interest since vitamin D concentrations
decrease with increased time spent indoors, decreased exposure to
sunlight, less exercise, obesity, and inadequate calcium intake.16
Additionally, a growing body of literature suggests that there is a
relationship between vitamin D status and asthma-related
respiratory symptoms,17-22 presumably through the immunomodulatory effects of vitamin D.23,24 This brief review discusses
vitamin D as it relates to asthma across the age spectrum, with
a focus on emerging human studies over the past decade. A
literature review was performed for relevant publications spanning from 2002 to present. Publications were limited to those
indexed on PubMed and written in English. Searches were made
for “vitamin D” and “asthma,” excluding in vitro and animal
studies. Relevant articles identified from this search are discussed
below.
e
i
c
s
o
i
B
.
e
s
t
e
u
d
b
i
n
r
a
t
L
s
i
2
d
1
t
0
o
2
n
o
©
D
Introduction
Asthma, one of the most prevalent diseases affecting people
worldwide, is a chronic respiratory disease characterized by
heightened airway inflammation, airway hyperresponsiveness and
airflow obstruction in response to specific triggers (Fig. 1).
Common symptoms include chest tightness, wheezing, cough
and difficulty breathing, which are commonly treated with two
different classes of medications: inhaled corticosteroids, used as a
daily controller medication, and β-adrenergic agonists, which are
used to induce bronchodilation.1 While the specific mechanisms
responsible for asthma are poorly understood, in part due to
the marked heterogeneity of the disorder in both adults2 and
children,3 numerous aberrant immune responses are clearly
associated with the disorder.4 For example, T-helper cell type-2
(TH2) cytokines, such as interleukin (IL)-4, IL-5, and IL-13, are
upregulated in the asthmatic airway and are associated with
increased eosinophilia,5,6 mast cell degranulation7 and increased
levels of immunoglobulin E (IgE).6,7 Impairment of immunogenic tolerance, along with complex interactions between cells
and inflammatory mediators, ultimately promotes airway injury
in a process commonly referred to as airway “remodeling.”8 This
*Correspondence to: Anne M. Fitzpatrick; Email:
Submitted: 01/20/12; Revised: 04/16/12; Accepted: 04/18/12
http://dx.doi.org/10.4161/derm.20434
www.landesbioscience.com
Vitamin D Overview
Vitamin D, a fat-soluble nutrient, is a secosteroid hormone which
is widely recognized as a modulator of calcium absorption and
bone health and further regulates neuromuscular function, cellular
differentiation, insulin secretion, and blood pressure.25,26 Vitamin
D also plays an important role in immune regulation through
interactions between 1,25-dihydroxyvitamin D and vitamin D
receptors (VDRs). VDRs are expressed on a variety of airway
immune cells, where they function as classic nuclear steroid
hormone receptors and ultimately regulate the transcription of
numerous genes associated with inflammation and immunomodulation.27 Vitamin D also plays an important role in respiratory infection by facilitating Toll-like receptor signaling
through increased synthesis of human cathelicidin antimicrobial
peptide,28-30 which is cleaved to generate the active cationic
peptide, LL-37.31,32 Vitamin D also exerts direct effects on target
Dermato-Endocrinology
137
previously associated with vitamin D deficiency in epidemiologic
studies.41-43
Vitamin D thresholds. Serum concentrations of 25(OH)D
are considered to be a biomarker and indicator of vitamin D
status.44,45 Although vitamin D insufficiency has traditionally
been defined as a serum 25(OH)D concentration of 20 to
29 ng/mL,46 a panel of experts from the Institute of Medicine
recently suggested that vitamin D insufficiency be redefined as
a serum 25(OH)D concentration less than 20 ng/mL.47 This
recommendation was based on inconclusive evidence for the
threshold of 29 ng/mL and evidence for adverse skeletal effects at
thresholds less than 20 ng/mL.47 However, this revised definition
of vitamin D insufficiency has generated significant controversy48,49 and thus there is presently no universally accepted
definition for “optimal” 25(OH)D concentrations independent
of musculoskeletal health.
.
e
nc
e
i
c
s
o
i
B
.
e
s
t
e
u
d
b
i
n
r
a
t
L
s
i
2
d
1
t
0
o
2
n
o
©
D
Maternal/Infant Vitamin D Exposure
and Childhood Respiratory Symptoms
Figure 1. Airway inflammation associated with asthma.
The rapid increase in asthma prevalence within Westernized
countries is unlikely solely due to genetics. Instead, a number of
environmental exposures may also alter the rate of asthma
development.50-54 Of these modifiable environmental exposures,
the role of diet in asthma is of particular interest13,55 since recent
studies (...truncated)